Friday, August 26, 2011

Compulsory licensing of generic drugs remains in quagmires

From the Institute for Health and Social Justice (IHSJ) Reader:

"Nearly a decade after the Doha Declaration determined that countries facing public health emergencies have the right to import generic drugs from developed countries, there has only been one instance in which a drug was successfully delivered to a developing country. Though several countries have enacted compulsory licensing legislation, the complicated application process deters low- and middle-income countries from turning to the EU or Canada to access cheaper treatment. Meanwhile, India, which has long served as the “pharmacy to the developing world,” is being forced to comply with international trade law by halting the production of generics patented after 1995."

Visit the IHSJ, the advocacy arm of Partners In Health.